Full metadata record

DC Field Value Language
dc.contributor.authorYoon, N.-
dc.contributor.authorJang, A.-K.-
dc.contributor.authorSeo, Y.-
dc.contributor.authorJung, B.H.-
dc.date.accessioned2024-01-19T13:03:35Z-
dc.date.available2024-01-19T13:03:35Z-
dc.date.created2022-02-17-
dc.date.issued2021-12-
dc.identifier.issn2218-1989-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/115962-
dc.description.abstractThe metabolomics approach represents the last downstream phenotype and is widely used in clinical studies and drug discovery. In this paper, we outline recent advances in the metabolomics research of autoimmune diseases (ADs) such as rheumatoid arthritis (RA), multiple sclerosis (MuS), and systemic lupus erythematosus (SLE). The newly discovered biomarkers and the metabolic mechanism studies for these ADs are described here. In addition, studies elucidating the metabolic mechanisms underlying these ADs are presented. Metabolomics has the potential to contribute to pharmacotherapy personalization; thus, we summarize the biomarker studies performed to predict the personalization of medicine and drug response. ? 2021 by the authors. Licensee MDPI, Basel, Switzerland.-
dc.languageEnglish-
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)-
dc.titleMetabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis-
dc.typeArticle-
dc.identifier.doi10.3390/metabo11120812-
dc.description.journalClass1-
dc.identifier.bibliographicCitationMetabolites, v.11, no.12-
dc.citation.titleMetabolites-
dc.citation.volume11-
dc.citation.number12-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000743070000001-
dc.identifier.scopusid2-s2.0-85121830494-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.type.docTypeArticle-
dc.subject.keywordPlusSTANDARDIZED FRANKINCENSE EXTRACT-
dc.subject.keywordPlusCEREBROSPINAL-FLUID-
dc.subject.keywordPlusT-CELLS-
dc.subject.keywordPlusACID-METABOLISM-
dc.subject.keywordPlusIMMUNE-SYSTEM-
dc.subject.keywordPlusDRUG RESPONSE-
dc.subject.keywordPlusBIOMARKERS-
dc.subject.keywordPlusNMR-
dc.subject.keywordPlusSIGNATURES-
dc.subject.keywordPlusMETHOTREXATE-
dc.subject.keywordAuthorAutoimmune disease-
dc.subject.keywordAuthorMetabolomics-
dc.subject.keywordAuthorPharmacometabolomics-
Appears in Collections:
KIST Article > 2021
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE